|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:FBXW11-RAC1 (FusionGDB2 ID:29804) |
Fusion Gene Summary for FBXW11-RAC1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: FBXW11-RAC1 | Fusion gene ID: 29804 | Hgene | Tgene | Gene symbol | FBXW11 | RAC1 | Gene ID | 23291 | 6035 |
Gene name | F-box and WD repeat domain containing 11 | ribonuclease A family member 1, pancreatic | |
Synonyms | BTRC2|BTRCP2|FBW1B|FBXW1B|Fbw11|Hos | RAC1|RIB1|RNS1 | |
Cytomap | 5q35.1 | 14q11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | F-box/WD repeat-containing protein 11F-box and WD repeats protein beta-TrCP2F-box and WD-40 domain protein 11F-box and WD-40 domain protein 1BF-box protein Fbw1bF-box/WD repeat-containing protein 1Bbeta-transducin repeat-containing protein 2homolog | ribonuclease pancreaticHP-RNaseRIB-1RNase 1RNase ARNase upI-1ribonuclease 1ribonuclease A C1ribonuclease, RNase A family, 1 (pancreatic) | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | Q9UKB1 | . | |
Ensembl transtripts involved in fusion gene | ENST00000296933, ENST00000265094, ENST00000393802, ENST00000425623, ENST00000522891, | ENST00000348035, ENST00000356142, ENST00000488373, | |
Fusion gene scores | * DoF score | 13 X 6 X 9=702 | 17 X 10 X 5=850 |
# samples | 13 | 18 | |
** MAII score | log2(13/702*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/850*10)=-2.23946593469539 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FBXW11 [Title/Abstract] AND RAC1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FBXW11(171433462)-RAC1(6439757), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FBXW11 | GO:0000209 | protein polyubiquitination | 20347421 |
Hgene | FBXW11 | GO:0016567 | protein ubiquitination | 16885022 |
Hgene | FBXW11 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 20347421 |
Hgene | FBXW11 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 20347421 |
Tgene | RAC1 | GO:0051607 | defense response to virus | 9826755 |
Tgene | RAC1 | GO:0090501 | RNA phosphodiester bond hydrolysis | 9826755 |
Fusion gene breakpoints across FBXW11 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across RAC1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-FP-8209-01A | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
Top |
Fusion Gene ORF analysis for FBXW11-RAC1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000296933 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
In-frame | ENST00000296933 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
5CDS-3UTR | ENST00000296933 | ENST00000488373 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
In-frame | ENST00000265094 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
In-frame | ENST00000265094 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
5CDS-3UTR | ENST00000265094 | ENST00000488373 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
In-frame | ENST00000393802 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
In-frame | ENST00000393802 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
5CDS-3UTR | ENST00000393802 | ENST00000488373 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
intron-3CDS | ENST00000425623 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
intron-3CDS | ENST00000425623 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
intron-3UTR | ENST00000425623 | ENST00000488373 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
intron-3CDS | ENST00000522891 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
intron-3CDS | ENST00000522891 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
intron-3UTR | ENST00000522891 | ENST00000488373 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000296933 | FBXW11 | chr5 | 171433462 | - | ENST00000348035 | RAC1 | chr7 | 6439757 | + | 2301 | 416 | 290 | 769 | 159 |
ENST00000296933 | FBXW11 | chr5 | 171433462 | - | ENST00000356142 | RAC1 | chr7 | 6439757 | + | 844 | 416 | 600 | 100 | 166 |
ENST00000265094 | FBXW11 | chr5 | 171433462 | - | ENST00000348035 | RAC1 | chr7 | 6439757 | + | 2068 | 183 | 57 | 536 | 159 |
ENST00000265094 | FBXW11 | chr5 | 171433462 | - | ENST00000356142 | RAC1 | chr7 | 6439757 | + | 611 | 183 | 57 | 536 | 159 |
ENST00000393802 | FBXW11 | chr5 | 171433462 | - | ENST00000348035 | RAC1 | chr7 | 6439757 | + | 2078 | 193 | 67 | 546 | 159 |
ENST00000393802 | FBXW11 | chr5 | 171433462 | - | ENST00000356142 | RAC1 | chr7 | 6439757 | + | 621 | 193 | 67 | 546 | 159 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000296933 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + | 0.022785144 | 0.9772149 |
ENST00000296933 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + | 0.02767181 | 0.9723282 |
ENST00000265094 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + | 0.007416593 | 0.9925834 |
ENST00000265094 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + | 0.012730984 | 0.98726904 |
ENST00000393802 | ENST00000348035 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + | 0.007372871 | 0.9926271 |
ENST00000393802 | ENST00000356142 | FBXW11 | chr5 | 171433462 | - | RAC1 | chr7 | 6439757 | + | 0.015093767 | 0.98490626 |
Top |
Fusion Genomic Features for FBXW11-RAC1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
FBXW11 | chr5 | 171433461 | - | RAC1 | chr7 | 6439756 | + | 8.57E-06 | 0.9999914 |
FBXW11 | chr5 | 171433461 | - | RAC1 | chr7 | 6439756 | + | 8.57E-06 | 0.9999914 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FBXW11-RAC1 |
Go to FGviewer for the breakpoints of chr5:171433462-chr7:6439757 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FBXW11 | . |
FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins. SCF(FBXW11) mediates the ubiquitination of phosphorylated CTNNB1 and participates in Wnt signaling. SCF(FBXW11) mediates the ubiquitination of phosphorylated NFKBIA, which degradation frees the associated NFKB1 to translocate into the nucleus and to activate transcription. SCF(FBXW11) mediates the ubiquitination of IFNAR1. SCF(FBXW11) mediates the ubiquitination of CEP68; this is required for centriole separation during mitosis (PubMed:25503564). Involved in the oxidative stress-induced a ubiquitin-mediated decrease in RCAN1. Mediates the degradation of CDC25A induced by ionizing radiation in cells progressing through S phase and thus may function in the intra-S-phase checkpoint. Has an essential role in the control of the clock-dependent transcription via degradation of phosphorylated PER1 and phosphorylated PER2. SCF(FBXW11) mediates the ubiquitination of CYTH1, and probably CYTH2 (PubMed:29420262). {ECO:0000269|PubMed:10321728, ECO:0000269|PubMed:10437795, ECO:0000269|PubMed:10644755, ECO:0000269|PubMed:10648623, ECO:0000269|PubMed:14532120, ECO:0000269|PubMed:14603323, ECO:0000269|PubMed:15917222, ECO:0000269|PubMed:18575781, ECO:0000269|PubMed:19966869, ECO:0000269|PubMed:20347421, ECO:0000269|PubMed:25503564, ECO:0000269|PubMed:29420262}.; FUNCTION: (Microbial infection) Target of human immunodeficiency virus type 1 (HIV-1) protein VPU to polyubiquitinate and deplete BST2 from cells and antagonize its antiviral action. {ECO:0000269|PubMed:19730691}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000348035 | 2 | 6 | 116_118 | 75.0 | 193.0 | Nucleotide binding | GTP | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000348035 | 2 | 6 | 159_160 | 75.0 | 193.0 | Nucleotide binding | GTP | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000356142 | 3 | 7 | 116_118 | 94.0 | 212.0 | Nucleotide binding | GTP | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000356142 | 3 | 7 | 159_160 | 94.0 | 212.0 | Nucleotide binding | GTP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 129_167 | 15.0 | 1360.3333333333333 | Domain | F-box |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 129_167 | 15.0 | 1283.6666666666667 | Domain | F-box |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 129_167 | 15.0 | 592.0 | Domain | F-box |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 67_116 | 15.0 | 1360.3333333333333 | Region | Homodimerization domain D |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 67_116 | 15.0 | 1283.6666666666667 | Region | Homodimerization domain D |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 67_116 | 15.0 | 592.0 | Region | Homodimerization domain D |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 238_275 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 1 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 278_315 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 2 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 318_355 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 3 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 361_398 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 4 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 401_440 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 5 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 442_478 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 6 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000265094 | - | 1 | 13 | 490_527 | 15.0 | 1360.3333333333333 | Repeat | Note=WD 7 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 238_275 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 1 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 278_315 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 2 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 318_355 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 3 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 361_398 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 4 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 401_440 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 5 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 442_478 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 6 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000296933 | - | 1 | 13 | 490_527 | 15.0 | 1283.6666666666667 | Repeat | Note=WD 7 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 238_275 | 15.0 | 592.0 | Repeat | Note=WD 1 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 278_315 | 15.0 | 592.0 | Repeat | Note=WD 2 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 318_355 | 15.0 | 592.0 | Repeat | Note=WD 3 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 361_398 | 15.0 | 592.0 | Repeat | Note=WD 4 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 401_440 | 15.0 | 592.0 | Repeat | Note=WD 5 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 442_478 | 15.0 | 592.0 | Repeat | Note=WD 6 |
Hgene | FBXW11 | chr5:171433462 | chr7:6439757 | ENST00000393802 | - | 1 | 12 | 490_527 | 15.0 | 592.0 | Repeat | Note=WD 7 |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000348035 | 2 | 6 | 32_40 | 75.0 | 193.0 | Motif | Effector region | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000356142 | 3 | 7 | 32_40 | 94.0 | 212.0 | Motif | Effector region | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000348035 | 2 | 6 | 13_18 | 75.0 | 193.0 | Nucleotide binding | GTP | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000348035 | 2 | 6 | 30_35 | 75.0 | 193.0 | Nucleotide binding | GTP | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000356142 | 3 | 7 | 13_18 | 94.0 | 212.0 | Nucleotide binding | GTP | |
Tgene | RAC1 | chr5:171433462 | chr7:6439757 | ENST00000356142 | 3 | 7 | 30_35 | 94.0 | 212.0 | Nucleotide binding | GTP |
Top |
Fusion Gene Sequence for FBXW11-RAC1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000296933_ENST00000348035_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(transcript)=2301nt_BP=416nt GTAGTCGTGGCGCTCTCGAGGCCCTGCCATGAGCAAGCTCTTAACTCTTCAGGTCTGCACGTCCTACGCCCACCGTCCAGTGCTACTCTC AGCTCGGAGTTCAGCTTCGGGCTGCCAAGAGCCAGCAACCTGGTGTCAGAGGCTCGGTCCCACAACGCTCTGCGGGCCGCGGCGCCTGCT GGGAGGTGTAGTCCCCGATCTGCGTACTGCGTTCGCCGAGGGGGAGGGCGGAGCTGCCGGCGGCCCGGGCGGGCTGGCAGCTAGAGTGGG TGCGATAGCCGCCTCCGCCTCTGCCGCCTCCGCCGTCGCCTCCTCCGCCCGGGCCGTTCGCTGCTGCGCGGGGAGAGCGAGGCGGGGCCG CCGGGGCCGCCATGGAGCCCGACTCGGTGATTGAGGACAAGACCATCGAGCTCATGGATGTGTTCTTAATTTGCTTTTCCCTTGTGAGTC CTGCATCATTTGAAAATGTCCGTGCAAAGTGGTATCCTGAGGTGCGGCACCACTGTCCCAACACTCCCATCATCCTAGTGGGAACTAAAC TTGATCTTAGGGATGATAAAGACACGATCGAGAAACTGAAGGAGAAGAAGCTGACTCCCATCACCTATCCGCAGGGTCTAGCCATGGCTA AGGAGATTGGTGCTGTAAAATACCTGGAGTGCTCGGCGCTCACACAGCGAGGCCTCAAGACAGTGTTTGACGAAGCGATCCGAGCAGTCC TCTGCCCGCCTCCCGTGAAGAAGAGGAAGAGAAAATGCCTGCTGTTGTAAATGTCTCAGCCCCTCGTTCTTGGTCCTGTCCCTTGGAACC TTTGTACGCTTTGCTCAAAAAAAAACAAAAAAAAAAAACAAAAAAAAAAAACAACGGTGGAGCCTTCGCACTCAATGCCAACTTTTTGTT ACAGATTAATTTTTCCATAAAACCATTTTTTGAACCAATCAGTAATTTTAAGGTTTTGTTTGTTCTAAATGTAAGAGTTCAGACTCACAT TCTATTAAAATTTAGCCCTAAAATGACAAGCCTTCTTAAAGCCTTATTTTTCAAAAGCGCCCCCCCCATTCTTGTTCAGATTAAGAGTTG CCAAAATACCTTCTGAACTACACTGCATTGTTGTGCCGAGAACACCGAGCACTGAACTTTGCAAAGACCTTCGTCTTTGAGAAGACGGTA GCTTCTGCAGTTAGGAGGTGCAGACACTTGCTCTCCTATGTAGTTCTCAGATGCGTAAAGCAGAACAGCCTCCCGAATGAAGCGTTGCCA TTGAACTCACCAGTGAGTTAGCAGCACGTGTTCCCGACATAACATTGTACTGTAATGGAGTGAGCGTAGCAGCTCAGCTCTTTGGATCAG TCTTTGTGATTTCATAGCGAGTTTTCTGACCAGCTTTTGCGGAGATTTTGAACAGAACTGCTATTTCCTCTAATGAAGAATTCTGTTTAG CTGTGGGTGTGCCGGGTGGGGTGTGTGTGATCAAAGGACAAAGACAGTATTTTGACAAAATACGAAGTGGAGATTTACACTACATTGTAC AAGGAATGAAAGTGTCACGGGTAAAAACTCTAAAAGGTTAATTTCTGTCAAATGCAGTAGATGATGAAAGAAAGGTTGGTATTATCAGGA AATGTTTTCTTAAGCTTTTCCTTTCTCTTACACCTGCCATGCCTCCCCAAATTGGGCATTTAATTCATCTTTAAACTGGTTGTTCTGTTA GTCGCTAACTTAGTAAGTGCTTTTCTTATAGAACCCCTTCTGACTGAGCAATATGCCTCCTTGTATTATAAAATCTTTCTGATAATGCAT TAGAAGGTTTTTTTGTCGATTAGTAAAAGTGCTTTCCATGTTACTTTATTCAGAGCTAATAAGTGCTTTCCTTAGTTTTCTAGTAACTAG GTGTAAAAATCATGTGTTGCAGCTTTATAGTTTTTAAAATATTTTAGATAATTCTTAAACTATGAACCTTCTTAACATCACTGTCTTGCC AGATTACCGACACTGTCACTTGACCAATACTGACCCTCTTTACCTCGCCCACGCGGACACACGCCTCCTGTAGTCGCTTTGCCTATTGAT GTTCCTTTGGGTCTGTGAGGTTCTGTAAACTGTGCTAGTGCTGACGATGTTCTGTACAACTTAACTCACTGGCGAGAATACAGCGTGGGA CCCTTCAGCCACTACAACAGAATTTTTTAAATTGACAGTTGCAGAATTGTGGAGTGTTTTTACATTGATCTTTTGCTAATGCAATTAGCA >In-frame_ENST00000296933_ENST00000348035_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(amino acids)=159AA_start in transcript=290_stop in transcript=769 MPPPPSPPPPGPFAAARGERGGAAGAAMEPDSVIEDKTIELMDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDK -------------------------------------------------------------- >In-frame_ENST00000296933_ENST00000356142_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(transcript)=844nt_BP=416nt GTAGTCGTGGCGCTCTCGAGGCCCTGCCATGAGCAAGCTCTTAACTCTTCAGGTCTGCACGTCCTACGCCCACCGTCCAGTGCTACTCTC AGCTCGGAGTTCAGCTTCGGGCTGCCAAGAGCCAGCAACCTGGTGTCAGAGGCTCGGTCCCACAACGCTCTGCGGGCCGCGGCGCCTGCT GGGAGGTGTAGTCCCCGATCTGCGTACTGCGTTCGCCGAGGGGGAGGGCGGAGCTGCCGGCGGCCCGGGCGGGCTGGCAGCTAGAGTGGG TGCGATAGCCGCCTCCGCCTCTGCCGCCTCCGCCGTCGCCTCCTCCGCCCGGGCCGTTCGCTGCTGCGCGGGGAGAGCGAGGCGGGGCCG CCGGGGCCGCCATGGAGCCCGACTCGGTGATTGAGGACAAGACCATCGAGCTCATGGATGTGTTCTTAATTTGCTTTTCCCTTGTGAGTC CTGCATCATTTGAAAATGTCCGTGCAAAGTGGTATCCTGAGGTGCGGCACCACTGTCCCAACACTCCCATCATCCTAGTGGGAACTAAAC TTGATCTTAGGGATGATAAAGACACGATCGAGAAACTGAAGGAGAAGAAGCTGACTCCCATCACCTATCCGCAGGGTCTAGCCATGGCTA AGGAGATTGGTGCTGTAAAATACCTGGAGTGCTCGGCGCTCACACAGCGAGGCCTCAAGACAGTGTTTGACGAAGCGATCCGAGCAGTCC TCTGCCCGCCTCCCGTGAAGAAGAGGAAGAGAAAATGCCTGCTGTTGTAAATGTCTCAGCCCCTCGTTCTTGGTCCTGTCCCTTGGAACC >In-frame_ENST00000296933_ENST00000356142_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(amino acids)=166AA_start in transcript=600_stop in transcript=100 MGVSFFSFSFSIVSLSSLRSSLVPTRMMGVLGQWCRTSGYHFARTFSNDAGLTREKQIKNTSMSSMVLSSITESGSMAAPAAPPRSPRAA -------------------------------------------------------------- >In-frame_ENST00000265094_ENST00000348035_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(transcript)=2068nt_BP=183nt CTGCCGGCGGCCCGGGCGGGCTGGCAGCTAGAGTGGGTGCGATAGCCGCCTCCGCCTCTGCCGCCTCCGCCGTCGCCTCCTCCGCCCGGG CCGTTCGCTGCTGCGCGGGGAGAGCGAGGCGGGGCCGCCGGGGCCGCCATGGAGCCCGACTCGGTGATTGAGGACAAGACCATCGAGCTC ATGGATGTGTTCTTAATTTGCTTTTCCCTTGTGAGTCCTGCATCATTTGAAAATGTCCGTGCAAAGTGGTATCCTGAGGTGCGGCACCAC TGTCCCAACACTCCCATCATCCTAGTGGGAACTAAACTTGATCTTAGGGATGATAAAGACACGATCGAGAAACTGAAGGAGAAGAAGCTG ACTCCCATCACCTATCCGCAGGGTCTAGCCATGGCTAAGGAGATTGGTGCTGTAAAATACCTGGAGTGCTCGGCGCTCACACAGCGAGGC CTCAAGACAGTGTTTGACGAAGCGATCCGAGCAGTCCTCTGCCCGCCTCCCGTGAAGAAGAGGAAGAGAAAATGCCTGCTGTTGTAAATG TCTCAGCCCCTCGTTCTTGGTCCTGTCCCTTGGAACCTTTGTACGCTTTGCTCAAAAAAAAACAAAAAAAAAAAACAAAAAAAAAAAACA ACGGTGGAGCCTTCGCACTCAATGCCAACTTTTTGTTACAGATTAATTTTTCCATAAAACCATTTTTTGAACCAATCAGTAATTTTAAGG TTTTGTTTGTTCTAAATGTAAGAGTTCAGACTCACATTCTATTAAAATTTAGCCCTAAAATGACAAGCCTTCTTAAAGCCTTATTTTTCA AAAGCGCCCCCCCCATTCTTGTTCAGATTAAGAGTTGCCAAAATACCTTCTGAACTACACTGCATTGTTGTGCCGAGAACACCGAGCACT GAACTTTGCAAAGACCTTCGTCTTTGAGAAGACGGTAGCTTCTGCAGTTAGGAGGTGCAGACACTTGCTCTCCTATGTAGTTCTCAGATG CGTAAAGCAGAACAGCCTCCCGAATGAAGCGTTGCCATTGAACTCACCAGTGAGTTAGCAGCACGTGTTCCCGACATAACATTGTACTGT AATGGAGTGAGCGTAGCAGCTCAGCTCTTTGGATCAGTCTTTGTGATTTCATAGCGAGTTTTCTGACCAGCTTTTGCGGAGATTTTGAAC AGAACTGCTATTTCCTCTAATGAAGAATTCTGTTTAGCTGTGGGTGTGCCGGGTGGGGTGTGTGTGATCAAAGGACAAAGACAGTATTTT GACAAAATACGAAGTGGAGATTTACACTACATTGTACAAGGAATGAAAGTGTCACGGGTAAAAACTCTAAAAGGTTAATTTCTGTCAAAT GCAGTAGATGATGAAAGAAAGGTTGGTATTATCAGGAAATGTTTTCTTAAGCTTTTCCTTTCTCTTACACCTGCCATGCCTCCCCAAATT GGGCATTTAATTCATCTTTAAACTGGTTGTTCTGTTAGTCGCTAACTTAGTAAGTGCTTTTCTTATAGAACCCCTTCTGACTGAGCAATA TGCCTCCTTGTATTATAAAATCTTTCTGATAATGCATTAGAAGGTTTTTTTGTCGATTAGTAAAAGTGCTTTCCATGTTACTTTATTCAG AGCTAATAAGTGCTTTCCTTAGTTTTCTAGTAACTAGGTGTAAAAATCATGTGTTGCAGCTTTATAGTTTTTAAAATATTTTAGATAATT CTTAAACTATGAACCTTCTTAACATCACTGTCTTGCCAGATTACCGACACTGTCACTTGACCAATACTGACCCTCTTTACCTCGCCCACG CGGACACACGCCTCCTGTAGTCGCTTTGCCTATTGATGTTCCTTTGGGTCTGTGAGGTTCTGTAAACTGTGCTAGTGCTGACGATGTTCT GTACAACTTAACTCACTGGCGAGAATACAGCGTGGGACCCTTCAGCCACTACAACAGAATTTTTTAAATTGACAGTTGCAGAATTGTGGA >In-frame_ENST00000265094_ENST00000348035_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(amino acids)=159AA_start in transcript=57_stop in transcript=536 MPPPPSPPPPGPFAAARGERGGAAGAAMEPDSVIEDKTIELMDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDK -------------------------------------------------------------- >In-frame_ENST00000265094_ENST00000356142_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(transcript)=611nt_BP=183nt CTGCCGGCGGCCCGGGCGGGCTGGCAGCTAGAGTGGGTGCGATAGCCGCCTCCGCCTCTGCCGCCTCCGCCGTCGCCTCCTCCGCCCGGG CCGTTCGCTGCTGCGCGGGGAGAGCGAGGCGGGGCCGCCGGGGCCGCCATGGAGCCCGACTCGGTGATTGAGGACAAGACCATCGAGCTC ATGGATGTGTTCTTAATTTGCTTTTCCCTTGTGAGTCCTGCATCATTTGAAAATGTCCGTGCAAAGTGGTATCCTGAGGTGCGGCACCAC TGTCCCAACACTCCCATCATCCTAGTGGGAACTAAACTTGATCTTAGGGATGATAAAGACACGATCGAGAAACTGAAGGAGAAGAAGCTG ACTCCCATCACCTATCCGCAGGGTCTAGCCATGGCTAAGGAGATTGGTGCTGTAAAATACCTGGAGTGCTCGGCGCTCACACAGCGAGGC CTCAAGACAGTGTTTGACGAAGCGATCCGAGCAGTCCTCTGCCCGCCTCCCGTGAAGAAGAGGAAGAGAAAATGCCTGCTGTTGTAAATG >In-frame_ENST00000265094_ENST00000356142_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(amino acids)=159AA_start in transcript=57_stop in transcript=536 MPPPPSPPPPGPFAAARGERGGAAGAAMEPDSVIEDKTIELMDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDK -------------------------------------------------------------- >In-frame_ENST00000393802_ENST00000348035_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(transcript)=2078nt_BP=193nt GAGGGCGGAGCTGCCGGCGGCCCGGGCGGGCTGGCAGCTAGAGTGGGTGCGATAGCCGCCTCCGCCTCTGCCGCCTCCGCCGTCGCCTCC TCCGCCCGGGCCGTTCGCTGCTGCGCGGGGAGAGCGAGGCGGGGCCGCCGGGGCCGCCATGGAGCCCGACTCGGTGATTGAGGACAAGAC CATCGAGCTCATGGATGTGTTCTTAATTTGCTTTTCCCTTGTGAGTCCTGCATCATTTGAAAATGTCCGTGCAAAGTGGTATCCTGAGGT GCGGCACCACTGTCCCAACACTCCCATCATCCTAGTGGGAACTAAACTTGATCTTAGGGATGATAAAGACACGATCGAGAAACTGAAGGA GAAGAAGCTGACTCCCATCACCTATCCGCAGGGTCTAGCCATGGCTAAGGAGATTGGTGCTGTAAAATACCTGGAGTGCTCGGCGCTCAC ACAGCGAGGCCTCAAGACAGTGTTTGACGAAGCGATCCGAGCAGTCCTCTGCCCGCCTCCCGTGAAGAAGAGGAAGAGAAAATGCCTGCT GTTGTAAATGTCTCAGCCCCTCGTTCTTGGTCCTGTCCCTTGGAACCTTTGTACGCTTTGCTCAAAAAAAAACAAAAAAAAAAAACAAAA AAAAAAAACAACGGTGGAGCCTTCGCACTCAATGCCAACTTTTTGTTACAGATTAATTTTTCCATAAAACCATTTTTTGAACCAATCAGT AATTTTAAGGTTTTGTTTGTTCTAAATGTAAGAGTTCAGACTCACATTCTATTAAAATTTAGCCCTAAAATGACAAGCCTTCTTAAAGCC TTATTTTTCAAAAGCGCCCCCCCCATTCTTGTTCAGATTAAGAGTTGCCAAAATACCTTCTGAACTACACTGCATTGTTGTGCCGAGAAC ACCGAGCACTGAACTTTGCAAAGACCTTCGTCTTTGAGAAGACGGTAGCTTCTGCAGTTAGGAGGTGCAGACACTTGCTCTCCTATGTAG TTCTCAGATGCGTAAAGCAGAACAGCCTCCCGAATGAAGCGTTGCCATTGAACTCACCAGTGAGTTAGCAGCACGTGTTCCCGACATAAC ATTGTACTGTAATGGAGTGAGCGTAGCAGCTCAGCTCTTTGGATCAGTCTTTGTGATTTCATAGCGAGTTTTCTGACCAGCTTTTGCGGA GATTTTGAACAGAACTGCTATTTCCTCTAATGAAGAATTCTGTTTAGCTGTGGGTGTGCCGGGTGGGGTGTGTGTGATCAAAGGACAAAG ACAGTATTTTGACAAAATACGAAGTGGAGATTTACACTACATTGTACAAGGAATGAAAGTGTCACGGGTAAAAACTCTAAAAGGTTAATT TCTGTCAAATGCAGTAGATGATGAAAGAAAGGTTGGTATTATCAGGAAATGTTTTCTTAAGCTTTTCCTTTCTCTTACACCTGCCATGCC TCCCCAAATTGGGCATTTAATTCATCTTTAAACTGGTTGTTCTGTTAGTCGCTAACTTAGTAAGTGCTTTTCTTATAGAACCCCTTCTGA CTGAGCAATATGCCTCCTTGTATTATAAAATCTTTCTGATAATGCATTAGAAGGTTTTTTTGTCGATTAGTAAAAGTGCTTTCCATGTTA CTTTATTCAGAGCTAATAAGTGCTTTCCTTAGTTTTCTAGTAACTAGGTGTAAAAATCATGTGTTGCAGCTTTATAGTTTTTAAAATATT TTAGATAATTCTTAAACTATGAACCTTCTTAACATCACTGTCTTGCCAGATTACCGACACTGTCACTTGACCAATACTGACCCTCTTTAC CTCGCCCACGCGGACACACGCCTCCTGTAGTCGCTTTGCCTATTGATGTTCCTTTGGGTCTGTGAGGTTCTGTAAACTGTGCTAGTGCTG ACGATGTTCTGTACAACTTAACTCACTGGCGAGAATACAGCGTGGGACCCTTCAGCCACTACAACAGAATTTTTTAAATTGACAGTTGCA GAATTGTGGAGTGTTTTTACATTGATCTTTTGCTAATGCAATTAGCATTATGTTTTGCATGTATGACTTAATAAATCCTTGAATCATACG >In-frame_ENST00000393802_ENST00000348035_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(amino acids)=159AA_start in transcript=67_stop in transcript=546 MPPPPSPPPPGPFAAARGERGGAAGAAMEPDSVIEDKTIELMDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDK -------------------------------------------------------------- >In-frame_ENST00000393802_ENST00000356142_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(transcript)=621nt_BP=193nt GAGGGCGGAGCTGCCGGCGGCCCGGGCGGGCTGGCAGCTAGAGTGGGTGCGATAGCCGCCTCCGCCTCTGCCGCCTCCGCCGTCGCCTCC TCCGCCCGGGCCGTTCGCTGCTGCGCGGGGAGAGCGAGGCGGGGCCGCCGGGGCCGCCATGGAGCCCGACTCGGTGATTGAGGACAAGAC CATCGAGCTCATGGATGTGTTCTTAATTTGCTTTTCCCTTGTGAGTCCTGCATCATTTGAAAATGTCCGTGCAAAGTGGTATCCTGAGGT GCGGCACCACTGTCCCAACACTCCCATCATCCTAGTGGGAACTAAACTTGATCTTAGGGATGATAAAGACACGATCGAGAAACTGAAGGA GAAGAAGCTGACTCCCATCACCTATCCGCAGGGTCTAGCCATGGCTAAGGAGATTGGTGCTGTAAAATACCTGGAGTGCTCGGCGCTCAC ACAGCGAGGCCTCAAGACAGTGTTTGACGAAGCGATCCGAGCAGTCCTCTGCCCGCCTCCCGTGAAGAAGAGGAAGAGAAAATGCCTGCT >In-frame_ENST00000393802_ENST00000356142_TCGA-FP-8209-01A_FBXW11_chr5_171433462_-_RAC1_chr7_6439757_length(amino acids)=159AA_start in transcript=67_stop in transcript=546 MPPPPSPPPPGPFAAARGERGGAAGAAMEPDSVIEDKTIELMDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FBXW11-RAC1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FBXW11-RAC1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FBXW11-RAC1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FBXW11 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Hgene | FBXW11 | C2677504 | AUTISM, SUSCEPTIBILITY TO, 15 | 1 | GENOMICS_ENGLAND |
Hgene | FBXW11 | C3550704 | Abnormality of digit | 1 | GENOMICS_ENGLAND |
Hgene | FBXW11 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Hgene | FBXW11 | C4021812 | Abnormality of the head | 1 | GENOMICS_ENGLAND |
Hgene | FBXW11 | C4316870 | Abnormality of the eye | 1 | GENOMICS_ENGLAND |
Tgene | RAC1 | C0011570 | Mental Depression | 2 | PSYGENET |
Tgene | RAC1 | C0011581 | Depressive disorder | 2 | PSYGENET |
Tgene | RAC1 | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human |
Tgene | RAC1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Tgene | RAC1 | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Tgene | RAC1 | C0018801 | Heart failure | 1 | CTD_human |
Tgene | RAC1 | C0018802 | Congestive heart failure | 1 | CTD_human |
Tgene | RAC1 | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
Tgene | RAC1 | C0023895 | Liver diseases | 1 | CTD_human |
Tgene | RAC1 | C0025202 | melanoma | 1 | CGI;CTD_human |
Tgene | RAC1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | RAC1 | C0086565 | Liver Dysfunction | 1 | CTD_human |
Tgene | RAC1 | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
Tgene | RAC1 | C0242698 | Ventricular Dysfunction, Left | 1 | CTD_human |
Tgene | RAC1 | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND |
Tgene | RAC1 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Tgene | RAC1 | C0876994 | Cardiotoxicity | 1 | CTD_human |
Tgene | RAC1 | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human |
Tgene | RAC1 | C1959583 | Myocardial Failure | 1 | CTD_human |
Tgene | RAC1 | C1961112 | Heart Decompensation | 1 | CTD_human |
Tgene | RAC1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | RAC1 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Tgene | RAC1 | C4540321 | MENTAL RETARDATION, AUTOSOMAL DOMINANT 48 | 1 | ORPHANET;UNIPROT |